Can diabetic drugs help you lose weight? Here’s what experts say
- GLP1 receptor agonists and SGLT2 inhibitors — are the new types of drugs which have been found to be effective in helping diabetics lose weight.
- These drugs remove glucose from the body via urinary excretion, thereby removing calories from the body.
Indiahas only one approved weight lossdrug and that too is very mild, doctors say and helps lose only 4% of body weight.
AdvertisementPeople who take diabetic drugs often witness changes in their body weight during the course of their treatment. However, new anti-diabetic drugs coming in the market are found to be very effective in weight loss, in addition to controlling blood glucose levels.
Does that mean these drugs can be used for the purpose they are not originally intended – only for weight loss? The world’s richest man and the new owner of Twitter,
@teslaownersSV @chicago_glenn @stillgray @dcherring @nichegamer Fasting + Ozempic/Wegovy + no tasty food near me— Elon Musk (@elonmusk) 1668580581000
In a tweet, he credited
How do these drugs cause weight loss?
Apart from the injectable, GLP1 receptor agonists and SGLT2 inhibitors are other types of diabetic drugs available in the market that have been found to be effective for weight loss.
“These drugs act through various mechanisms, for instance, they work by increasing the removal of glucose from the body via urinary excretion, thereby leading to the loss of calories from the body,” Dr Brij Mohan
Inj Semaglutide drug acts on the brain to reduce appetite, slow gastric emptying, and reduce blood pressure to some extent, all of which have favourable effects on the metabolism. This drug suppresses appetite through its action on the brain, which gives a feeling of fullness.
“The drug has been studied in many clinical trials and found safe. The injection needs to be taken once a week and continued for the long term,” Dr Makkar said. He also believes that they do not cause major side effects. “The side effects, if any, are usually mild and subside shortly after treatment initiation,” he added.
AdvertisementAre they affordable?
In addition to weight loss, anti-diabetic drugs help control other metabolic diseases too. GLP1 receptor agonists and SGLT2 inhibitors also help protect against cardiovascular events. “These classes of drugs showed cardiovascular benefits in studies,” Dr Reddy added.
SGLT2 drugs also help in preventing heart failures and are now being used as the first treatment by cardiologists, even among non-diabetics, according to Dr Mohan.
Other drugs like
Another diabetic drug called Liraglutide is recommended by doctors for purely weight loss in many countries like the USA, even among non-diabetics, Dr Mohan added.
AdvertisementHowever, none of the SGLT2 inhibitors have received approval for weight loss so far, in India. Weight loss drugs themselves are few in India.
“Currently, only one approved weight loss drug is available in India, and it acts by blocking the absorption of fat. But the drawback is that it is a very mild drug and helps in losing only about 4% of the body weight. It acts differently than diabetes weight loss drugs,” Dr Makkar said.
Dr Mohan also highlighted that these two classes of drugs – GLP1 and SGLT2 agent drugs — are highly expensive and beyond the reach of a common man.
SEE ALSO: Indian markets open lower amid unrest in China over zero-Covid: Paytm, Adani Transmission, Hero MotoCorp in focus
Canada to strengthen visa processing capacity in Delhi and Chandigarh
Dharmaj Crop Guard IPO – 10 things to know before subscribing
Popular on BI
- A laid-off Microsoft software engineer on an H1-B visa said she wonders 'where will I be living' with just 60 days to find a new job
- A Google engineer found out she had been laid off while she was on vacation when her boss sent her a LinkedIn message
- Laid-off Google employees are turning to a Discord server with nearly 18,000 members for emotional support and financial advice
- WhatsApp rolls out ability to create avatars on iOS
- One in four users unaware of crypto cybercrime risks: Cybersecurity firm Kaspersky
- Telegram adds real-time message translation in its new update
- Global smartphone revenue fall by 9% in 2022: Counterpoint Research
- Ex-military ruler Pervez Musharraf dies in Dubai: Pak media